TP53 and sarcoma: Apart from explaining why iPCs generated from H358 and H460 were not TP53 null and CDKN2A null, respectively, this may answer an intriguing question posed by Zhang and colleagues as to how a reprogrammed sarcoma cell with multiple genetic-level damage could still achieve pluripotency [5].